Literature DB >> 27837676

Cerebellar volume mediates the relationship between FMR1 mRNA levels and voluntary step initiation in males with the premutation.

Darren R Hocking1, Rachael C Birch2, Quang M Bui3, Jasmine C Menant4, Stephen R Lord5, Nellie Georgiou-Karistianis6, David E Godler7, Wei Wen8, Anna Hackett9, Carolyn Rogers10, Julian N Trollor11.   

Abstract

Recent evidence indicates that adults with a premutation (PM: 55-199 CGG repeats) expansion in the fragile X mental retardation 1 (FMR1) gene show postural control deficits that may reflect disruption to cerebellar motor regions. Less is known about the influence of reduced cerebellar volume and structural changes, and increase in CGG repeat and FMR1 mRNA levels on the attentional demands of step initiation in PM males. We investigated the effects of a concurrent cognitive task on choice stepping reaction time (CSRT) and explored the associations between CSRT performance, cerebellar volume, CGG size, and FMR1 mRNA levels in blood in PM males. We examined 19 PM males (ages 28-75) and 23 matched controls (CGG <44; ages 26-77), who performed a verbal fluency task during CSRT performance and single-task stepping without a secondary cognitive task. Our results provide preliminary evidence that smaller cerebellar volume (β = -2.73, p = 0.002) and increasing CGG repeat length (β = 1.69, p = 0.003) were associated with greater dual-task step initiation times in PM males, but not in controls. There was evidence of a mediating effect of cerebellar volume on the relationship between FMR1 mRNA levels and single-task CSRT performance in PM males (estimate coefficient = 8.69, standard error = 4.42, p = 0.049). These findings suggest increasing CGG repeat and FMR1 mRNA levels have neurotoxic effects on cerebellar regions underlying anticipatory postural responses during stepping. Cerebellar postural changes may be predictive of the increased risk of falls in older PM males.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebellar motor networks; Choice stepping reaction time; Cognitive-motor interference; FMR1 premutation carrier; Fragile X mental retardation gene 1 (FMR1); Motor symptoms; Postural balance; Step initiation

Mesh:

Substances:

Year:  2016        PMID: 27837676     DOI: 10.1016/j.neurobiolaging.2016.10.017

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  5 in total

Review 1.  Balance and the brain: A review of structural brain correlates of postural balance and balance training in humans.

Authors:  Olivia J Surgent; Olga I Dadalko; Kristen A Pickett; Brittany G Travers
Journal:  Gait Posture       Date:  2019-05-06       Impact factor: 2.840

2.  Consensus Paper: Ataxic Gait.

Authors:  Pierre Cabaraux; Sunil K Agrawal; Huaying Cai; Rocco Salvatore Calabro; Carlo Casali; Loic Damm; Sarah Doss; Christophe Habas; Anja K E Horn; Winfried Ilg; Elan D Louis; Hiroshi Mitoma; Vito Monaco; Maria Petracca; Alberto Ranavolo; Ashwini K Rao; Serena Ruggieri; Tommaso Schirinzi; Mariano Serrao; Susanna Summa; Michael Strupp; Olivia Surgent; Matthis Synofzik; Shuai Tao; Hiroo Terasi; Diego Torres-Russotto; Brittany Travers; Jaimie A Roper; Mario Manto
Journal:  Cerebellum       Date:  2022-04-12       Impact factor: 3.847

3.  Complexity based measures of postural stability provide novel evidence of functional decline in fragile X premutation carriers.

Authors:  Clodagh O'Keeffe; Laura P Taboada; Niamh Feerick; Louise Gallagher; Timothy Lynch; Richard B Reilly
Journal:  J Neuroeng Rehabil       Date:  2019-07-12       Impact factor: 4.262

4.  β-glucuronidase use as a single internal control gene may confound analysis in FMR1 mRNA toxicity studies.

Authors:  Claudine M Kraan; Kim M Cornish; Quang M Bui; Xin Li; Howard R Slater; David E Godler
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

5.  Static and dynamic postural control deficits in aging fragile X mental retardation 1 (FMR1) gene premutation carriers.

Authors:  Zheng Wang; Pravin Khemani; Lauren M Schmitt; Su Lui; Matthew W Mosconi
Journal:  J Neurodev Disord       Date:  2019-01-21       Impact factor: 4.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.